Literature DB >> 24773426

Effect of muscle metaboreflex activation on central hemodynamics and cardiac function in humans.

Clare L McNulty1, William E Moody, Anton J M Wagenmakers, James P Fisher.   

Abstract

We sought to determine how the mode of muscle metaboreflex activation influences the central hemodynamic response and cardiac inotropic and lusotropic function in healthy humans. Ten healthy males performed (i) isometric handgrip (IHG) with and without post-exercise ischemia (PEI) to examine the influence of isolated muscle metaboreflex activation and (ii) rhythmic handgrip (RHG) with and without ischemia to examine the influence of enhanced muscle metaboreflex activation. Heart rate (HR) and blood pressure (BP) were continuously monitored. Stroke volume (SV, Doppler echocardiography) was measured, cardiac output (CO = HR × SV) and total peripheral resistance (TPR = mean BP/CO) calculated, and indices of left ventricular systolic and diastolic function were obtained (tissue Doppler imaging). During isolated muscle metaboreflex activation with PEI following IHG, mean BP (+23 ± 3 mm Hg) and TPR were elevated from baseline (p < 0.05), whereas HR, SV, and CO were unchanged. Enhanced muscle metaboreceptor activation during ischemic RHG augmented the increase in mean BP, CO, and HR (p < 0.05 ischemic vs. free-flow RHG), whereas SV and TPR were unchanged from baseline. Neither isolated (PEI) nor enhanced muscle metaboreflex activation altered left ventricular systolic function (systolic myocardial velocity), but left atrial systolic function (late diastolic myocardial velocity) was enhanced. These findings indicate that the mode of muscle metaboreceptor activation (during vs. post handgrip) determines whether the resultant pressor response is flow (CO) or vasoconstriction (TPR) mediated, and that although left ventricular systolic function is unchanged, enhanced left atrial systolic function likely aids the preservation of SV during muscle metaboreflex engagement.

Entities:  

Keywords:  Exercise; autonomic nervous system; cardiovasculaire; cardiovascular; exercice physique; système nerveux autonome

Mesh:

Year:  2014        PMID: 24773426     DOI: 10.1139/apnm-2013-0414

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  5 in total

1.  Metaboreflex activation delays heart rate recovery after aerobic exercise in never-treated hypertensive men.

Authors:  Tiago Peçanha; Leandro Campos de Brito; Rafael Yokoyama Fecchio; Patricia Nascimento de Sousa; Natan Daniel da Silva Junior; Andrea Pio de Abreu; Giovanio Vieira da Silva; Décio Mion-Junior; Cláudia Lúcia de Moraes Forjaz
Journal:  J Physiol       Date:  2016-09-21       Impact factor: 5.182

2.  Effect of aging on hemodynamic response to metaboreflex activation.

Authors:  Raffaele Milia; Silvana Roberto; Gabriele Mulliri; Andrea Loi; Maura Marcelli; Gianmarco Sainas; Nicola Milia; Elisabetta Marongiu; Antonio Crisafulli
Journal:  Eur J Appl Physiol       Date:  2015-03-24       Impact factor: 3.078

Review 3.  Clinical safety of blood flow-restricted training? A comprehensive review of altered muscle metaboreflex in cardiovascular disease during ischemic exercise.

Authors:  Michelle Cristina-Oliveira; Kamila Meireles; Marty D Spranger; Donal S O'Leary; Hamilton Roschel; Tiago Peçanha
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-11-08       Impact factor: 4.733

4.  Muscle metaboreflex-induced vasoconstriction in the ischemic active muscle is exaggerated in heart failure.

Authors:  Jasdeep Kaur; Danielle Senador; Abhinav C Krishnan; Hanna W Hanna; Alberto Alvarez; Tiago M Machado; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-09-22       Impact factor: 4.733

5.  Ischemic preconditioning reduces hemodynamic response during metaboreflex activation.

Authors:  Gabriele Mulliri; Gianmarco Sainas; Sara Magnani; Girolamo Palazzolo; Nicola Milia; Andrea Orrù; Silvana Roberto; Elisabetta Marongiu; Raffaele Milia; Antonio Crisafulli
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-02       Impact factor: 3.619

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.